Ferraris sells respiratory division to nSpire Health
This article was originally published in Clinica
Executive Summary
Ferraris has completed the sale to private investors of its loss-making respiratory division for $3.9m. The Birmingham, UK-based firm, which in July sold its cardiac business, Del Mar Reynolds Medical, for £14m ($27m), is narrowing its focus to in vitro diagnostics control solutions and X-ray crystallography cryosystems only.